MedPath

GENOTROPIN

GENOTROPIN

Approved
DIN Number

02401797

Drug Class

Human

Market Date

Sep 18, 2013

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02401797
AIG Number0131827019
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
H01AC01 SOMATROPIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification68:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOMATROPINActive
Strength: 1.2 MG / SYR
Monograph: SOMATROPIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.